FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition for the treatment and prevention of prostate cancer containing (S)-4-(3-(4-(2,3-dihydroxypropoxy) phenyl) - 4,4-dimethyl-5-carbonyl-2-thioimidazole n-1-yl) - 2-(trifluoromethyl)benzonitrile as the active ingredient and hydroxypropyl cellulose, which is present in an amount of 0.5 to 10 wt %, relative to the total weight of the pharmaceutical composition. The present invention also relates to a method for preparing the pharmaceutical composition and to the use of the pharmaceutical composition.
EFFECT: obtaining a composition that has good stability, dissolution rate and biological availability.
11 cl, 7 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING A BICYCLO-SUBSTITUTED AZO DERIVATIVE OF PYRAZOLONE OR A SALT THEREOF, AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2733844C2 |
| METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION COMPRISING A QUINOLINE DERIVATIVE OR SALT THEREOF | 2017 |
|
RU2735807C2 |
| OXOTHIOIMIDAZOLINE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND APPLICATION IN MEDICINE AS ANDROGEN RECEPTOR INHIBITORS | 2013 |
|
RU2639145C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING A QUINOLINE DERIVATIVE OR SALT THEREOF | 2017 |
|
RU2743014C2 |
| PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2630617C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DGAT1 INHIBITOR | 2011 |
|
RU2595866C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2767872C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE DERIVATIVE | 2010 |
|
RU2548673C2 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING TLR7 AGONIST | 2020 |
|
RU2822480C2 |
| COMPOSITION OF THE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR | 2014 |
|
RU2661399C1 |
